Collaboration with Quadram Institute Bioscience Will Focus on New Therapies for Immune-Related Conditions DuPont Nutrition and Biosciences announced a 3-year project to study gut bacteria's influence the immune system. The company is partnering with Quadram Institute Bioscience (QIB) to complete the focus. The research will evaluate how extracellular vesicles (EVs), which are naturally produced by the
Janssen ( a Johnson and Johnson Company) Submits Application to U.S. FDA Seeking Approval of New DARZALEX® (daratumumab) Subcutaneous Formulation, Innovative Treatment for Multiple Myeloma RARITAN, N.J., July 12, 2019 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson announced today the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration
Next Generation Precision Oncology and Infectious Disease To Be Discussed At Basel Computational Biology Conference In Switzerland
Join the international [BC]2 conference and EMBO meeting at BASEL LIFE from 9–12 September: a unique opportunity for today’s scientists to get insights and share the latest discoveries, resources and approaches to make sense of genomic and health-related “big data” for molecular medicine – from precision oncology to infectious diseases. Advances in next generation
Beauty and brain-boosting, collagen-enhanced coffee blend named “Best Health Drink” by leading natural beauty blog awards Modere’s new cognitive-enhancing collagen and hyaluronic acid-based proprietary coffee blend, Modere Logiq™ with TetraBlend™ Coffee, has won the prestigious 2019 Beauty Shortlist Mama & Baby Award for “Best Health Drink” in the awards’ wellbeing category. Modere Logiq™ with TetraBlend™
Skinuva™ Scar, Founded By Beverly Hills Based Dr. Christopher Zoumalan, is a next-generation new scar cream that is the first to use highly selective growth factors in its unique formulation. Skinuva™ Scar is a next-generation new scar cream that is the first of its kind to use highly selective growth factors in its unique formulation.
DermBiont, a clinical stage therapeutics company dedicated to the discovery and development of live bacterial products for the treatment of skin diseases has closed an $8M Series A. The funding round was led by Zola Global Investors, Toba Capital, and Viking Global Investors. The financing proceeds will be used to fund ongoing clinical trials and
"The idea and research behind this infographic was developed by Write my essay"
Working out more often and other fitness-related goals are the most common New Year’s resolution, but it can be difficult to make time and find motivation for exercise during the winter. If you didn’t gain the momentum you wanted over the winter, that doesn’t mean it’s too late to get started now. While many people
Internationally Recognized Handbook Provides Expert Overview of Essential Microorganisms Prominent scientists have contributed to what is the 5th edition of the most comprehensive handbook on lactic acid bacteria, the key microorganisms in probiotics and fermented foods. Edited by DuPont Nutrition & Biosciences Technical Fellow Arthur Ouwehand, Ph.D., together with professors Seppo Salminen, Atte von Wright,
Global Hospital Acquired MRSA Infections outlook through 2028 has been published and is now available to purchase from PioneerReports.com The market report provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections by providing the disease overview, definition, classification, symptoms, etiology, pathophysiology, and diagnostic methods. It also covers the detailed treatment approaches and